Malignant Neoplasm of Stomach Unknown Status Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01618474Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer PatientsTreatment
NCT00961077Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric CancerTreatment
NCT00985556Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric CancerTreatment
NCT01090505Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric CancerTreatment
NCT01471132Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum MetastasisTreatment
NCT01798251XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of StomachTreatment
NCT01963702A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGCTreatment
NCT01980407Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric CancerTreatment